Health Care & Life Sciences » Biotechnology | Spark Therapeutics Inc.

Spark Therapeutics Inc.

Spark Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 37.57 M
Public Float
 18.71 M
Spark Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $2.36
Market Cap
 $3.89 B
Shares Outstanding
 38.41 M
Public Float
 34.81 M

Profile

Address
3737 Market Street
Philadelphia Pennsylvania 19104
United States
Employees -
Website http://www.sparktx.com
Updated 07/08/2019
Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A.

Financials

View All
Created with Highcharts 5.0.14Spark Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.57 27757 27724 32424 32447 12547 125123 652123 652253 482253 48278 82278 822201320142015201620172018050k100k150k200k250k300k
Created with Highcharts 5.0.14Spark Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.0063363322 06322 06320 18220 18212 06512 06564 72564 725201320142015201620172018020k40k60k80k

Katherine A. High
President, Director & Head-Research & Development
Jeffrey D. Marrazzo
Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.